A Phase 1 Study to Investigate the Pharmacokinetics of ANJ900 (Metformin Hydrochloride Delayed-release Tablets) and the Effect of Food on the Pharmacokinetics of ANJ900 in Chinese Healthy Subjects
Latest Information Update: 09 Jun 2022
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Anji Pharma
- 02 Jun 2022 Status changed from active, no longer recruiting to completed, according to an Anji Pharma media release.
- 14 Dec 2021 Planned primary completion date changed from 30 Nov 2021 to 30 Dec 2021.
- 13 Dec 2021 New trial record